Literature DB >> 17512409

Curved EFC/F-BAR-domain dimers are joined end to end into a filament for membrane invagination in endocytosis.

Atsushi Shimada1, Hideaki Niwa, Kazuya Tsujita, Shiro Suetsugu, Koji Nitta, Kyoko Hanawa-Suetsugu, Ryogo Akasaka, Yuri Nishino, Mitsutoshi Toyama, Lirong Chen, Zhi-Jie Liu, Bi-Cheng Wang, Masaki Yamamoto, Takaho Terada, Atsuo Miyazawa, Akiko Tanaka, Sumio Sugano, Mikako Shirouzu, Kuniaki Nagayama, Tadaomi Takenawa, Shigeyuki Yokoyama.   

Abstract

Pombe Cdc15 homology (PCH) proteins play an important role in a variety of actin-based processes, including clathrin-mediated endocytosis (CME). The defining feature of the PCH proteins is an evolutionarily conserved EFC/F-BAR domain for membrane association and tubulation. In the present study, we solved the crystal structures of the EFC domains of human FBP17 and CIP4. The structures revealed a gently curved helical-bundle dimer of approximately 220 A in length, which forms filaments through end-to-end interactions in the crystals. The curved EFC dimer fits a tubular membrane with an approximately 600 A diameter. We subsequently proposed a model in which the curved EFC filament drives tubulation. In fact, striation of tubular membranes was observed by phase-contrast cryo-transmission electron microscopy, and mutations that impaired filament formation also impaired membrane tubulation and cell membrane invagination. Furthermore, FBP17 is recruited to clathrin-coated pits in the late stage of CME, indicating its physiological role.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17512409     DOI: 10.1016/j.cell.2007.03.040

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  190 in total

1.  Serine 77 in the PDZ domain of PICK1 is a protein kinase Cα phosphorylation site regulated by lipid membrane binding.

Authors:  Ina Ammendrup-Johnsen; Thor S Thorsen; Ulrik Gether; Kenneth L Madsen
Journal:  Biochemistry       Date:  2012-01-06       Impact factor: 3.162

2.  Cloning, purification, crystallization and preliminary X-ray diffraction analysis of mouse PACSIN 3 protein.

Authors:  Xiaoyun Bai; Geng Meng; Xiaofeng Zheng
Journal:  Acta Crystallogr Sect F Struct Biol Cryst Commun       Date:  2012-01-25

Review 3.  Role of phosphoinositides at the neuronal synapse.

Authors:  Samuel G Frere; Belle Chang-Ileto; Gilbert Di Paolo
Journal:  Subcell Biochem       Date:  2012

4.  Structural basis of membrane bending by the N-BAR protein endophilin.

Authors:  Carsten Mim; Haosheng Cui; Joseph A Gawronski-Salerno; Adam Frost; Edward Lyman; Gregory A Voth; Vinzenz M Unger
Journal:  Cell       Date:  2012-03-30       Impact factor: 41.582

5.  The F-BAR domains from srGAP1, srGAP2 and srGAP3 regulate membrane deformation differently.

Authors:  Jaeda Coutinho-Budd; Vladimir Ghukasyan; Mark J Zylka; Franck Polleux
Journal:  J Cell Sci       Date:  2012-03-30       Impact factor: 5.285

6.  Determinants of endocytic membrane geometry, stability, and scission.

Authors:  Takuma Kishimoto; Yidi Sun; Christopher Buser; Jian Liu; Alphée Michelot; David G Drubin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-10-17       Impact factor: 11.205

Review 7.  Synaptic vesicle endocytosis.

Authors:  Yasunori Saheki; Pietro De Camilli
Journal:  Cold Spring Harb Perspect Biol       Date:  2012-09-01       Impact factor: 10.005

8.  Nonlinear sorting, curvature generation, and crowding of endophilin N-BAR on tubular membranes.

Authors:  Chen Zhu; Sovan L Das; Tobias Baumgart
Journal:  Biophys J       Date:  2012-04-18       Impact factor: 4.033

9.  Multiple modes of endophilin-mediated conversion of lipid vesicles into coated tubes: implications for synaptic endocytosis.

Authors:  Naoko Mizuno; Christine C Jao; Ralf Langen; Alasdair C Steven
Journal:  J Biol Chem       Date:  2010-05-18       Impact factor: 5.157

Review 10.  Grab your partner with both hands: cytoskeletal remodeling by Arp2/3 signaling.

Authors:  Scott H Soderling
Journal:  Sci Signal       Date:  2009-01-27       Impact factor: 8.192

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.